iOS app Android app

Patent Law Drugs

The Cost of Cancer Drugs and Research

Erin Havel | Posted 06.09.2013 | Healthy Living
Erin Havel

In their Intellectual property case, the pharmaceutical company Novartis was asking to block a generic form of their cancer drug Gleevec from being created and sold by India. As a writer and also a person living with chronic myelogenous leukemia, I understand both sides of the battle.